Tandlæge Sofie Møller Lumholtz ApS
CVR number: 37139807
Østerbrogade 148, 2100 København Ø
kontakt@svaneklinikken.dk
tel: 39294741
www.svaneklinikken.dk
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 9 382.60 | 8 480.16 | 9 303.74 | 10 157.78 | 12 181.42 |
| Employee benefit expenses | -7 671.62 | -7 605.43 | -8 308.37 | -9 346.70 | -10 316.75 |
| Other operating expenses | -20.00 | ||||
| Total depreciation | - 519.84 | - 544.35 | - 579.49 | - 972.36 | -1 059.13 |
| EBIT | 1 191.14 | 310.38 | 415.88 | - 161.28 | 805.54 |
| Other financial income | 1.85 | 1.30 | 2.05 | 1.21 | 0.02 |
| Other financial expenses | - 479.93 | - 300.56 | - 315.87 | - 666.94 | - 646.77 |
| Pre-tax profit | 713.06 | 11.12 | 102.06 | - 827.00 | 158.80 |
| Income taxes | - 160.97 | -6.96 | -18.06 | 218.88 | -8.25 |
| Net earnings | 552.09 | 4.16 | 84.00 | - 608.13 | 150.55 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Development expenditure | 1 776.39 | 1 757.78 | 1 739.16 | 1 720.54 | |
| Intangible rights | 1 795.01 | ||||
| Goodwill | 3 712.77 | 3 486.57 | 3 260.38 | 3 034.18 | 2 807.99 |
| Intangible assets total | 5 507.78 | 5 262.97 | 5 018.16 | 4 773.34 | 4 528.53 |
| Machinery and equipment | 1 465.19 | 1 226.65 | 1 865.28 | 5 070.62 | 4 460.59 |
| Tangible assets total | 1 465.19 | 1 226.65 | 1 865.28 | 5 070.62 | 4 460.59 |
| Other receivables | 15.00 | 15.00 | 107.40 | 107.40 | 107.40 |
| Investments total | 15.00 | 15.00 | 107.40 | 107.40 | 107.40 |
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 262.58 | 222.74 | 236.35 | 233.80 | 207.44 |
| Prepayments and accrued income | 36.89 | 23.60 | 11.20 | 18.24 | |
| Current other receivables | 18.44 | 42.64 | 52.76 | 45.35 | 131.30 |
| Current deferred tax assets | 50.00 | 6.00 | 6.00 | 3.00 | |
| Short term receivables total | 317.91 | 338.99 | 306.31 | 285.15 | 359.97 |
| Cash and bank deposits | 624.16 | 172.32 | 65.86 | 71.94 | 381.40 |
| Cash and cash equivalents | 624.16 | 172.32 | 65.86 | 71.94 | 381.40 |
| Balance sheet total (assets) | 7 930.04 | 7 015.92 | 7 363.01 | 10 308.45 | 9 837.89 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Shares repurchased | 110.60 | 113.00 | 114.40 | 122.00 | |
| Retained earnings | 1 184.11 | 1 623.21 | 1 512.97 | 1 596.97 | 866.84 |
| Profit of the financial year | 552.09 | 4.16 | 84.00 | - 608.13 | 150.55 |
| Shareholders equity total | 1 896.81 | 1 790.37 | 1 761.37 | 1 038.84 | 1 189.39 |
| Provisions | 574.60 | 581.56 | 599.62 | 380.75 | 389.00 |
| Non-current loans from credit institutions | 2 606.22 | 222.63 | |||
| Non-current other liabilities | 110.96 | ||||
| Non-current liabilities total | 2 717.18 | 222.63 | |||
| Current loans from credit institutions | 282.00 | 690.84 | 379.63 | 4 506.63 | 4 796.61 |
| Advances received | 38.63 | 30.30 | 41.30 | 27.83 | 27.40 |
| Current trade creditors | 281.53 | 298.24 | 334.50 | 331.26 | 379.77 |
| Short-term deferred tax liabilities | 40.26 | ||||
| Other non-interest bearing current liabilities | 2 099.03 | 3 401.98 | 4 246.58 | 4 023.14 | 3 055.73 |
| Current liabilities total | 2 741.45 | 4 421.37 | 5 002.02 | 8 888.86 | 8 259.51 |
| Balance sheet total (liabilities) | 7 930.04 | 7 015.92 | 7 363.01 | 10 308.45 | 9 837.89 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.